Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics

Journal of Diabetes Investigation(2024)10.1111/jdi.14225Source: DataRank Database

Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics is a research paper published in Journal of Diabetes Investigation (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.

N/A

0.241DataRank · unranked

Scored on demand from live citation data

4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 1.03)OA: goldTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (11)

Yoshihide Fukumoto,Gendai Lee,Yoshifumi Yokomizo,Kokichi Tanaka,Michiko Chosa

Live enrichment

PubMed:38700282 PMC:PMC11363112 OpenAlex:https://openalex.org/W4396612060

FWCI

1.03

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.14225

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.14225

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.14225

journalhttps://doi.org/10.1111/jdi.14225

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38700282

Fields of Study

Diabetes Treatment and ManagementBariatric Surgery and OutcomesMetabolism, Diabetes, and Cancer

MeSH Terms

East Asian PeopleGlucagon-Like Peptide-1 Receptor AgonistsSemaglutideAdministration, OralAgedBlood GlucoseDiabetes Mellitus, Type 2Glucagon-Like PeptidesFemaleGlycated HemoglobinHumansHypoglycemic AgentsJapanMaleMiddle AgedRetrospective StudiesTreatment Outcome

Keywords

SemaglutideMedicineTolerabilityInternal medicineGlycated hemoglobinBody mass indexDiabetes mellitusType 2 diabetesDulaglutideAdverse effectType 2 Diabetes MellitusGastroenterologyLiraglutideEndocrinologyGlucagon‐like Peptide 1 Receptor AgonistOral Semaglutide

Sustainable Development Goals

SDG 0: Good health and well-being